Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children a retrospective analysis

Klinische Padiatrie

Volumn 221, Issue 2, 2009, Pages 69-73

  Eymann, R ^a   Steudel, W I ^a   Kiefer, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Antibiotic impregnated catheter; Children; Hydrocephalus; Shunt infection

Indexed keywords

CLINDAMYCIN; ELASTOMER; RIFAMPICIN; SILICONE; ANTIINFECTIVE AGENT; BIOMATERIAL;

ANTIBIOTIC IMPREGNATED SHUNT CATHETER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BRAIN HEMORRHAGE; BRAIN VENTRICULITIS; CATHETER; CEREBROSPINAL FLUID CULTURE; CHILD; CONTROLLED STUDY; DISSOLUTION; DRUG RELEASE; DRUG TARGETING; FEMALE; FOLLOW UP; HUMAN; HYDROCEPHALUS; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; NEWBORN; OPERATION DURATION; POINT MUTATION; PREMATURITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SHUNT INFECTION; SHUNTING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL ANALYSIS; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; WOUND INFECTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTING; CROSS INFECTION; INSTRUMENTATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PRESCHOOL CHILD; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; COATED MATERIALS, BIOCOMPATIBLE; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCEPHALUS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 65549101505     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1119397     Document Type: Article

References (26)

1. Bayston R, Lari J. A study of the sources of infection in colonised shunts: developmental. Medicine and Child Neurology 1974 16 (Suppl. 32) 16-22
2. Bayston R, Grove N, Siegel J et al. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 1989 52 605-609
3. Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydocephalus shunts. J Antimicrob chemoth 2004 53 778-782
4. Choux M, Genitori L, Lang D et al. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992 77 (6) 875-880
5. Cochrane DD, Kestle JRW. The influence of surgical operative experience on the duration of first ventriculo-peritoneal shunt function and infection. Pediatr Neurosurg 2003 38 295-301
6. Enger P, Svendsen F, Wester K. CSF shunt infections in children: experiences from a population- based study. Acta Neurochirurg.(Wien) 2003 145 243-248
7. Finney HL, Roberts TS. Nephritis to chronic cerebrospinal fluid- vascular shunt infection: shunt nephritis Childs Brain 1980 6 (4) 189-193
8. Furno F, Morley KS, Wong B et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemoth 2004 54 1019-1024
9. Govender ST, Nathoo N, Van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 2003 99 831-839
10. Hager J, Häussler B, Sanal M. Abdominelle Liquorpseudocysten-seltene Komplikationen bei mit einem Ventilsystem versorgten hydrocephalen Kindern. Klin Pädiatr 2007 219 102
11. Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Child's Nerv Syst 2007 23 773-777
12. Kockro RA, Hampül JA, Jansen B et al. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 2000 49 (5) 441-450
13. Kubota M, Sakata Y, Saecki N et al. A case of shunt nephritis diagnosed 17 years after ventriculoatrial shunt implantation. Clin Neurol Neurosurg 2001 103 245-246
14. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal shunt infection: a prospective study of risk factors. J Neurosurg 2001 94 195-201
15. Legrain V, Fontan D, Pujol JF et al. Cutaneous vasculitis disclosing shunt nephritis. Ann Dematol Venerol 1993 120 (11) 788-789
16. Mac Girt MJ, Zaas A, Fuchs HE et al. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003 36 858-862
17. Pattavilakom A, Kotasnas D, Korman TM et al. Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery 2006 58 930-935
18. Pople I, Bayston R, Hayward RD. Infection of cerebrospinal fluid shunts in infants: a study of aetiological factors. J Neurosurg 1992 77 29-36
19. Renier D, Sainte-Rose C, Pierre-Kahn A et al. Prenatal hydrocephalus: outcome and prognosis. Child's nervous system 1988 4 213-222
20. Reinprecht A, Dietrich W, Berger A et al. Posthemorrhagic hydrocephalus in preterm infants: long-term follow-up and shunt related complications. Child's Nerv Syst 2001 17 663-669
21. Resch B, Müller W, Oberbauer R. Precipitating factors for shunt insufficiency in posthemorrhagic hydrocephalus in the premature infant. Z Kinderch. 1990 45 (4) 203-208
22. Ritz R, Roser F, Morgalla M et al. Do antibiotic impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC infect Dis 2007 7 38
23. Roitberg BZ, Tomita T, Mac Lone DG. Abdominal cerebrospinal fluid pseudocyst: a complication of ventriculoperitoneal shunt in children. Pediatr Neurosurg 1998 29 267-273
24. Sciubba DM, MacGirt MJ, Woodworth GF et al. Prolonged exposure to antibiotic impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 2007 23 (8) 867-871
25. Sciubba DM, Noggle JC, Carson BS et al. Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus. Pediatr Neurosurg 2008 44 91-96
26. Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 2006 22 692-697